EN DE

Dynamic Medical Technologies Inc (4138) Fair Value & Analysis

Healthcare · TW · Market cap 2.0B TWD

DM Dynamic Medical Technologies Inc 4138 · TWO
Price51.10 TWD
Fair Value71.21 TWD
Upside+39.4%
Quality56/100
Watch Dynamic Medical Technologies Inc for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Solidly profitable · 10.4% net margin
Low debt · generates free cash flow
8.25% dividend yield
Ranks above peers (13/14)
Moderate moat 48/100
Evidence: Medium Range 53.41 TWD – 89.01 TWD Share as image

Fair value as of: Jul 21, 2026

From 24 valuation models · updated 20 days ago

Share price +0.4% over the past month.

A solid business, screening 39% undervalued on our models.

What matters now

  • The price is below even our cautious bear case (53.41 TWD). The market is more pessimistic than our downside scenario.
  • Solid quality (56/100) at a price below fair value, the discount is the argument here, not the business quality.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

150.00 TWD 42.72 TWD Fair Value 71.21 TWD Mar 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.

How to read this chart

60‑month range 42.72 TWD – 150.00 TWD · fair‑value band 53.41 TWD – 89.01 TWD · the 51.10 TWD price screens below the 71.21 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 21, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Dynamic Medical Technologies Inc (4138) currently trades at 51.10 TWD, while our model-based Fair Value estimate is 71.21 TWD, implying the stock looks roughly 39.4% undervalued today. The Quality Score stands at 56/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.

Over the trailing twelve months, Dynamic Medical Technologies Inc generated revenue of 1.4B TWD at a net margin of 10.4%. Revenue declined 2.4% year over year. It earns a return on equity of 9.7%. The balance sheet holds a net cash position of 483M TWD. Fundamentals as of Jul 21, 2026

Our scenario range runs from 53.41 TWD (bear case) to 89.01 TWD (bull case); at 51.10 TWD, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 34% below its 52-week high and 2% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -22% fair-value upside, at 39%, 4138 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 84.29 TWD 105.68 TWD 138.64 TWD 80
Residual Income 35.68 TWD 38.82 TWD 46.89 TWD 76
Rev-Margin DCF 66.94 TWD 87.05 TWD 110.97 TWD 74
All 24 models by family
DCF Models
FCF DCF 82.17 TWD 104.50 TWD 141.31 TWD 38
Owner Earnings 78.92 TWD 100.13 TWD 135.07 TWD 31
5Y Revenue Exit 66.94 TWD 85.86 TWD 111.54 TWD 39
5Y EBITDA Exit 89.68 TWD 124.95 TWD 168.61 TWD 41
5Y P/E Exit 76.24 TWD 101.85 TWD 130.29 TWD 38
10Y Revenue Exit 71.31 TWD 88.61 TWD 108.29 TWD 36
10Y EBITDA Exit 86.14 TWD 113.99 TWD 146.15 TWD 37
10Y P/E Exit 78.04 TWD 99.00 TWD 120.73 TWD 35
Earnings-Based
Graham-Dodd 25.90 TWD 47.81 TWD 59.24 TWD 54
EPV 46.80 TWD 51.33 TWD 55.24 TWD 59
Dividend Discount
Gordon GGM 33.13 TWD 43.65 TWD 54.03 TWD 70
DDM Multi-Stage 33.13 TWD 44.87 TWD 58.34 TWD 61
Multiples
P/E Multiple 62.83 TWD 83.78 TWD 104.72 TWD 63
P/S Multiple 48.55 TWD 64.74 TWD 80.92 TWD 58
P/B Multiple 48.55 TWD 64.74 TWD 80.92 TWD 55
EV/EBIT 77.37 TWD 97.12 TWD 116.88 TWD 53
EV/EBITDA 106.22 TWD 135.60 TWD 164.97 TWD 54
EV/Revenue 60.40 TWD 78.53 TWD 96.66 TWD 43
Asset-Based
NCAV (Graham) 20.89 TWD 28.00 TWD 41.79 TWD 50
Growth DCF
Growth DCF 84.29 TWD 105.68 TWD 138.64 TWD 80
Rev-Margin DCF 66.94 TWD 87.05 TWD 110.97 TWD 74
Economic Profit
Residual Income 35.68 TWD 38.82 TWD 46.89 TWD 76
ROIC Compounder 47.17 TWD 52.71 TWD 58.35 TWD 72
Growth Earnings
Growth-Adj P/E 44.57 TWD 63.67 TWD 82.77 TWD 68

Widest divergence: DCF Models (100.13 TWD) versus Asset-Based (28.00 TWD). Highest evidence: Growth DCF (80).

Notify me when 4138 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 1.4B TWD
Revenue growth (YoY) -2.4%
Net margin 10.4%
Return on equity 9.7%
Free cash flow 263M TWD FY2025
P/E ratio 13.5
More key figures
Operating margin 10.0%
EPS (TTM) 3.79 TWD
Dividend yield 8.3%
EPS growth (YoY) -20.2%
Net cash 483M TWD FY2023

Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 56/100

Of which business quality 58 · Market factors (momentum, volatility) 37

Profitability 39
Margins and returns on capital today
Quality Growth 46
Are margins and returns improving?
Cashflow 85
Earnings quality: real cash, not paper profit
Fin. Strength 82
Balance sheet, leverage, solvency risk
Investment 77
Disciplined investing over empire-building
Low Volatility 96
Calm price path (market factor)
Momentum 19
Price trend over the last 3–12 months (market factor)
52W Momentum 2
Distance to the 52-week high (market factor)
Net Issuance 8
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Dynamic Medical Technologies Inc., together with its subsidiaries, engages in the sale, maintenance, and marketing of aesthetic lasers and light-based equipment in Taiwan and Hong Kong. It distributes and sells aesthetic medical devices, body contouring devices, dermal fillers, and cosmeceuticals.

Full company description

Dynamic Medical Technologies Inc., together with its subsidiaries, engages in the sale, maintenance, and marketing of aesthetic lasers and light-based equipment in Taiwan and Hong Kong. It distributes and sells aesthetic medical devices, body contouring devices, dermal fillers, and cosmeceuticals. The company also provides aesthetician training and clinical operation consultation services. In addition, it sells beauty treatment and cosmetic products. The company was founded in 1992 and is headquartered in New Taipei City, Taiwan.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Dynamic Medical Technologies Inc reported revenue of 1.4B TWD in FY2025 versus 1.0B TWD in FY2021, a compound +7.8%/yr. Reported net income was 152M TWD in FY2025, compounding +5.4%/yr from FY2021.

Growth Quality 72/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
1.4B TWD
Latest YoY
−11.8%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+2.4%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+6.6%
Avg. growth/yr (9Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+1.5%
Revenue +7.8%/yr
FY21 1.0B TWD
FY22 1.3B TWD
FY23 1.6B TWD
FY24 1.6B TWD
FY25 1.4B TWD
Net income +5.4%/yr
FY21 123M TWD
FY22 137M TWD
FY23 210M TWD
FY24 205M TWD
FY25 152M TWD

Watch 4138: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Dynamic Medical Technologies Inc Fair Value". https://www.fairvalue-calculator.com/stock/4138

Peer Group

Medical Devices · 352 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 56 · Above median
Fair Value upside +39% · Top 25%
Return on equity (TTM) 10% · Above median
Return on assets 4% · Above median
Net margin (TTM) 10% · Above median
Operating margin (TTM) 10% · Above median
Revenue growth -2% · Below median
Dividend yield (TTM) 8.3% · Top 25%

Valuation Multiples vs Medical Devices median · lower = cheaper

P/E (TTM) 13.5× · Cheaper than 75% of peers
P/B 1.22× · Cheaper than median
P/S (TTM) 1.48× · Cheaper than median
P/FCF 0.2× · Cheaper than 75% of peers
EV/EBITDA 4.8× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 86 · sector 0
FUTURE 0 · sector 29
PAST 39 · sector 8
HEALTH 100 · sector 97
DIVIDEND 100 · sector 38

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).

Stock Price Fair Value vs Fair Value
Abbott Laboratories, ABT $100.68 $74.79 -26%
Stryker Corporation SYK $316.44 $186.28 -41%
Medtronic plc MDT $83.56 $65.57 -22%
Boston Scientific Corporation BSX $43.04 $38.44 -11%
Edwards Lifesciences Corporation EW $85.73 $41.02 -52%
Siemens Healthineers AG SHL €34.59 €33.87 -2%
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥149.43 ¥147.63 -1%
Shanghai United Imaging Healthcare Co 688271 ¥109.00 ¥43.60 -60%
Demant A/S DEMANT kr 276.60 kr 161.17 -42%
Getinge AB GETIB kr 206.80 kr 192.14 -7%

Compare Dynamic Medical Technologies Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Dynamic Medical Technologies Inc (4138) overvalued or undervalued?
As of Jul 21, 2026, our model estimates a fair value of 71.21 TWD versus a price of 51.10 TWD, about +39% (undervalued).
What is the fair value of 4138?
Our model-based fair value for Dynamic Medical Technologies Inc is 71.21 TWD (as of Jul 21, 2026), built from audited fundamentals. The current price is 51.10 TWD.
What is the quality score of 4138?
Dynamic Medical Technologies Inc has a Quality Score of 56/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Dynamic Medical Technologies Inc (4138)?
Dynamic Medical Technologies Inc reported trailing-twelve-month revenue of about 1.4B TWD (latest available figure, as of Jul 21, 2026).
What is the net profit margin of 4138?
The net profit margin of Dynamic Medical Technologies Inc is about 10.4%, meaning it keeps roughly 10.4% of revenue as net income. Based on the latest reported figures.
Does Dynamic Medical Technologies Inc pay a dividend?
Dynamic Medical Technologies Inc currently shows a dividend yield of about 8.20% relative to its recent price (as of Jul 21, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Dynamic Medical Technologies Inc and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.